The risk of Pneumocystis carinii pneumonia.
暂无分享,去创建一个
J. Goedert | J. Phair | A. Muñoz | C. Rinaldo | R. Kaslow | A. Saah | A. Labriola | J. Felser | R. Detels | F. Hecht
[1] J. Phair,et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. , 1990, The New England journal of medicine.
[2] F. Ognibene,et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. , 1989, Annals of internal medicine.
[3] M A Fischl,et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.
[4] J. Goedert,et al. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. , 1987, JAMA.
[5] E. Gelmann,et al. ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX , 1986, The Lancet.
[6] J. Mills,et al. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. , 1984, Annals of internal medicine.